ZJU-USYD Dialogue Series: Eye and Cancer Joint Seminar

Date: 2022-11-02 10:00:00
Time: 2nd Nov. 2022 10:00am-12:00pm(Beijing)
Venue: Online
Speaker: Prof. Andrew McLachlan & Prof. Bo Yang
Category: Talk & Lecture

Speaker: Prof. Andrew McLachlan(Head of Sydney Pharmacy School, The University of Sydney)

                 Prof. Bo Yang(Dean of The Sci-Tech Academy, Zhejiang University)

                 A/Prof. Fanfan Zhou(The University of Sydney)

                 A/Prof. Michele Madigan(The University of Sydney)

                 Dr. Ling Zhu(The University of Sydney)

                 Prof. Qiaojun He(Zhejiang University)

                 Prof. Hong Zhu(Zhejiang University)

                 Prof. Jin-Jian Lu(University of Macau)

                 Prof. Bei Jin(Sun Yat-sen University)

                 Prof. Ke Wang(Jiangsu Institute of Nuclear Medicine)

Venue: Online

             Zoom Meeting ID: 893 4602 6481

             Meeting Link: https://uni-sydney.zoom.us/j/89346026481


The University of Sydney (USYD) and Zhejiang University (ZJU) are strategic partners, and both have a strong commitment to addressing society’s greatest challenges and advancing the drug development of human diseases. Both universities have notable research achievements in therapeutic development in human eye diseases and cancers.

Jointly Hosted by the Sydney School of Pharmacy (USYD) and College of Pharmacy (ZJU), participated by University of Macau and Sun Yat-sen University. This workshop is to encourage constructive dialogues and explore collaborations to improve clinical outcomes in human eye diseases and cancers.

It has relevance to World Health Organization (WHO) – One Health initiative. Specific topics to be covered include general knowledge advancement on eye health, immunotherapy development in eye diseases and cancers and the applications of novel technologies in eye disease and cancer treatment.

The workshop will be beneficial to those who would like to take advantage of international research opportunities and particularly relevant to early career researchers who are keen to develop their global network.